USD 5.07 billion
Global Compounding Chemotherapy Market Size, Share, Growth Analysis, By Drug(Cytotoxic Drugs, Hormonal Agents), By Dose(Chemotherapeutic, and Non-Chemotherapeutics), By Delivery method(Gravimetric Automated Compounding Devices, and Volumetric Automated Compounding Devices), By Sterility(Sterile, and Non-Sterile), By Technology(Robotic Arms, and Without Robotic Arms) - Industry Forecast 2024-2031
Report ID:
SQMIG35A2813 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|
Tables:
142 |
Figures:
72
Global Compounding Chemotherapy Market Insights
Global Compounding Chemotherapy Market size was valued at USD 5.07 billion in 2022 and is poised to grow from USD 5.33 billion in 2023 to USD 7.92 billion by 2031, growing at a CAGR of 5.08% in the forecast period (2024-2031).
The global compounding chemotherapy market is witnessing significant expansion driven by several key factors. The increasing incidences of cancer and the continuous advancements in pharmaceutical compounding technologies play pivotal roles in fueling market growth. The rising geriatric population, more susceptible to cancer, further contributes to the expanding market as personalized treatment becomes increasingly vital.
Despite these growth drivers, the market faces certain constraints, including stringent regulatory requirements and safety concerns associated with compounding chemotherapy, underscoring the importance of compliance and patient safety. Conversely, there are promising opportunities on the horizon, such as the ongoing development of innovative compounding technologies and the increasing adoption of precision medicine approaches.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Chemotherapeutic
Fastest Growth
Chemotherapeutic
Growth Rate
5.08% CAGR
Global Compounding Chemotherapy Market ($ Bn)
Country Share for North america Region (%)
Global Compounding Chemotherapy Market By Dose ($ Bn)
Global Compounding Chemotherapy Market By Dose (%)
To get more reports on the above market click here to Buy The Report
Global Compounding Chemotherapy Market Segmental Analysis
By drug type, the market is segmented into cytotoxic drugs, hormonal agents, immunomodulatory agents, targeted therapies, and supportive care drugs. Based on Dose, the Compounding Chemotherapy market segmentation includes Chemotherapeutic and Non-Chemotherapeutics. Based on the delivery method, the Compounding Chemotherapy market segmentation includes Gravimetric Automated Compounding Devices and Volumetric Automated Compounding Devices. Based on Sterility, the Compounding Chemotherapy market data includes Sterile and Non-Sterile. Based on Technology, the Compounding Chemotherapy market data includes With Robotic Arms and Without Robotic Arms. By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World.
Analysis by End-Use
In the compounding chemotherapy market data for 2022, the chemotherapeutic segment emerged as the dominant force holding the majority of the share. The popularity of the chemotherapy segment can be attributed to the high effectiveness of chemotherapeutic agents, which is a key factor in the overall expansion of the market. These drugs play an important role in cancer treatment, and how they fly effectiveness contributes greatly to market dominance. In addition, the major factors driving the growth and growth of this market are the aging population and increasing incidence of cancer.
The non-pharmaceutical segment plays an important role in the combination therapeutics market by offering a range of products beyond conventional therapeutics This segment includes a variety of treatments such as adjuvants, antidepressants, painkillers, etc. Drugs aimed at reducing side effects and enhancing overall patient well-being in cancer treatment If drugs non-drug therapy along with combination therapy, allows for a comprehensive and tailored approach to patient care, addressing not only basic cancer treatments but also complications and associated symptoms.
Analysis by Product
The gravimeter automatic assembly machine segment asserted its dominance in the market by 2022 and is anticipated to continue as the fastest growing segment during the forecast period extended from 2023 to 2031. These automatic assembly machines provide accurate measurement and accuracy by weight, ensuring well-made pharmaceuticals.
Volume automated assembly segment plays a key role in the compound chemotherapy market, offering complementary options for formulation. These devices operate on precise dosimetry, enable precise formulation of drug compounds, meet drug specific requirements for metering, and also ensure rate consistency and minimizes variation.
Global Compounding Chemotherapy Market By Dose, 2022 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Global Compounding Chemotherapy Market Regional Insights
By 2022, North America will continue to be the leading market for generic therapeutics, accounting for the largest share of 45.80%. This regional leadership is attributed to several key factors, including the high prevalence of cancer, which highlights the critical need for effective treatment solutions, in addition to the high demand for personalized cancer care, namely the tendency to match the treatment designed for them. The preference for combination therapies over commercially available alternatives further contributes to the industry’s market reputation.
By 2022, Asia Pacific emerged as the third largest market for combination therapies, with a share of 15.00%. Several key factors have driven growth in this segment, including the increasing incidence of cancer, which drives the demand for effective personalized cancer care solutions A major factor driving preferred chemotherapy combinations than a wide selection of commercial chemicals
Global Compounding Chemotherapy Market By Region, 2024-2031
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Global Compounding Chemotherapy Market Dynamics
Drivers
Growing Demand for Generic Drugs
- The shift towards personalized medicine presents huge opportunities for the combination therapy market. With health care professionals increasingly acknowledging the importance of personalized therapeutic approaches, the demand for personalized therapeutics has increased dramatically. Combination therapy occupies a unique position and it will take advantage of this trend by providing the ability to tailor treatments to patient-specific features. By simplifying custom formulations, the product addresses a growing paradigm in chemotherapy health, where personalized approaches are increasingly recognized as essential for healing the successful results.
Restraints
- Lack of Standardized Practices
A major challenge in the market stems from the lack of standardized practices and formulations. The incompatibility of pharmaceutical and pharmaceutical formulations raises concerns about the stability and reliability of combination therapeutics Differences in pharmaceutical composition, stability, and potency of the drugs can lead to inconsistent clinical outcomes for patients. The lack of a standardized drug combination protocol is a barrier for health professionals, making it difficult to compare and evaluate different combinations of drugs.
Request Free Customization of this report to help us to meet your business objectives.
Global Compounding Chemotherapy Market Competitive Landscape
The competitive environment of the global Compounding Chemotherapy market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor.
Top Player’s Company Profiles
- B. Braun Melsungen AG
- Fagron NV
- PharMEDium Services, LLC (AmerisourceBergen Corporation)
- Baxter International Inc.
- Fresenius Kabi AG
- Advanced Pharma, Inc.
- McGuff Compounding Pharmacy Services, Inc.
- Central Admixture Pharmacy Services, Inc. (CAPS)
- Institutional Pharmacy Solutions, LLC
- Wedgewood Pharmacy
- Medisca Inc.
- Dougherty's Holdings, Inc.
- PharMEDium Services, LLC (AmerisourceBergen Corporation)
- BioScrip, Inc.
Recent Developments
- On July 13, 2023, Revelation Pharma acquired both Eagle Pharmacy, LLC and Lee Silsby Pharmacy, combining pharmacies with specific market operations to form Eagle Pharmacy, 2023. LLCA generic pharmacy provider, available to patients in 29 states and territories in the U.S , expands its services to prescribers and pharmacies This acquisition provides Revelation Pharma with valuable assets to ensure it delivers Eagle's capabilities there to make it use. Additionally, the move is expected to diversify Revelation's offerings and create new growth opportunities within their broader platform.
- On October 20, 2023, pharmaceutical company Pharmakeio Custom Compounding expanded its footprint by acquiring a new location in Conway. The ultimate goal of FarmaKeio Custom Compounding is to support the healthcare revolution by providing personalized compounding and exceptional service to patients and physicians nationwide. This expansion aligns with FarmaKeio’s goal of personalized medicine, and emphasizes the importance of customized medicine solutions to meet the unique needs of patients and healthcare professionals. These acquisitions and expansions indicate dynamic growth and development in the compound medicine industry. Carefully crafted to prevent plagiarism, this paragraph provides insight into notable acquisitions in the pharmaceutical industry.
Global Compounding Chemotherapy Key Market Trends
- Pharmacogenomics is the study of how an individual’s genetic makeup affects their response to drugs. This field delves into the complex interactions between genetic variation and its effects on drug exposure and response. Insights gained from pharmacokinetics empower healthcare providers to optimize treatment strategies, with the goal of optimizing outcomes for individual patients. In the development of compound therapies, the integration of pharmacotherapeutic data is particularly valuable. By harnessing this knowledge, combination therapies can tailor drugs to a patient’s unique genotype. By doing so, health care providers can maximize the effectiveness of treatment and reduce the risk of side effects.
Global Compounding Chemotherapy Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. The compound therapeutics market is experiencing significant growth driven by various factors. The main cause of cancer is the increasing incidence of cancer, creating a growing need for effective treatment. At the same time, there is a growing demand for personalized cancer care, reflecting a shift toward personalized treatment. Combination therapies are gaining popularity among the industries of choice due to their ability to adapt to the needs of individual patients, contributing to market expansion Furthermore, the adoption of advanced technologies in drug delivery blending pharmaceuticals plays an important role in the efficiency and precision of drug therapy combination strategies In line with the increase in demand, where specialized drugs are in high demand, it is expected that this combination of factors will fuel the growth of the compound therapeutics market in the near future.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 5.07 billion |
| Market size value in 2031 | USD 7.92 billion |
| Growth Rate | 5.08% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Global Compounding Chemotherapy Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global Compounding Chemotherapy Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Global Compounding Chemotherapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Compounding Chemotherapy Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Compounding Chemotherapy Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Compounding Chemotherapy Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global Compounding Chemotherapy Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
